Board of Directors
 |
David Blackett (Treasurer)
Vice President of Marketing and Strategy
PerkinElmer ViaCord
Waltham, Massachusetts
2014-2022
|
 |
Jaap Jan Boelens, MD, PhD
Chief of Service, Pediatric Transplant and Cellular Therapies
Memorial Sloan Kettering Cancer Center
New York, New York
2016-2021
|
 |
Haywood Brown, MD
Chair, Obstetrics and Gynecology
Duke University School of Medicine
Durham, North Carolina
2014-2022
|
 |
Calvin Cole
Vice President of Sales
Celularity
Warren, New Jersey
2016-2022
|
 |
Colleen Delaney, MD, MSc (Vice President)
Founder and Scientific Director
Deverra Therapeutics
Seattle, Washington
2014-2021
|
 |
Arthur Flatau, PhD
Patient Advocate
Bone Marrow Transplant Survivor
Austin, Texas
2014-2020
|
 |
Joanie Y. Hare, MD
Maternal Fetal Medicine
Houston Perinatal Associates
Houston, Texas
2016-2020
|
 |
Elaine Hsieh
Chair and Chief Executive Officer
Sino Cell Technologies
Taipei, Taiwan
2017-2020
|
 |
Richard D. Jennings, MBA
Chief Executive Officer
California Cryobank Life Sciences
Los Angeles, California
2019-2021
|
 |
Wolfgang Knirsch, PhD
Chief Executive Officer
Vita 34 AG
Leipzig, Germany
2018-2023
|
 |
Gesine Koegler, PhD (Secretary)
Jose Carreras Cord Blood Bank and GMP Facility Director
University of Duesseldorf Medical Center
Duesseldorf, Germany
2014-2021
|
 |
Joanne Kurtzberg, MD (President)
Director
Carolinas Cord Blood Bank
Durham, North Carolina
2014-2020
|
 |
Charles Lu, MBA
Chief Commercial Officer
Mononuclear Therapeutics Ltd.
Hong Kong
2019-2023
|
 |
Aby J. Mathew, PhD
Senior Vice President & Chief Technology Officer
BioLife Solutions, Inc.
Bothell, Washington
2014-2022
|
 |
Beth H. Shaz, MD
Chief Medical Officer & Senior Vice President
New York Blood Center
New York, New York
2014-2022
|
 |
John E. Wagner, Jr., MD
Professor, Department of Pediatrics
University of Minnesota
Minneapolis, Minnesota
2018-2023
|
 |
Jeffrey Wilson
Assistant Director of Operations
MD Anderson Cord Blood Bank
Houston, Texas
2018-2023
|
| |
|
|
